Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bradley Allen Maron, M.D.

Co-Author

This page shows the publications co-authored by Bradley Maron and Jane Leopold.
Connection Strength

10.193
  1. Precision Medicine in Pulmonary Arterial Hypertension. Circ Res. 2019 03 15; 124(6):832-833.
    View in: PubMed
    Score: 0.829
  2. Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease. Glob Cardiol Sci Pract. 2016 Sep 30; 2016(3):e201627.
    View in: PubMed
    Score: 0.700
  3. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci. 2016 May 18; 17(5).
    View in: PubMed
    Score: 0.682
  4. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension. Circulation. 2015 Jun 09; 131(23):2079-91.
    View in: PubMed
    Score: 0.639
  5. New thematic series: recent advances in pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1771.
    View in: PubMed
    Score: 0.614
  6. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ. 2014 Jun; 4(2):200-10.
    View in: PubMed
    Score: 0.595
  7. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation. 2014 Jul 08; 130(2):168-79.
    View in: PubMed
    Score: 0.591
  8. Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials). Am J Cardiol. 2013 Sep 01; 112(5):720-5.
    View in: PubMed
    Score: 0.556
  9. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83.
    View in: PubMed
    Score: 0.533
  10. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012 Aug 21; 126(8):963-74.
    View in: PubMed
    Score: 0.522
  11. Aldosterone receptor antagonists: effective but often forgotten. Circulation. 2010 Feb 23; 121(7):934-9.
    View in: PubMed
    Score: 0.443
  12. Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem. 2009 Mar 20; 284(12):7665-72.
    View in: PubMed
    Score: 0.410
  13. Mineralocorticoid receptor antagonists and endothelial function. Curr Opin Investig Drugs. 2008 Sep; 9(9):963-9.
    View in: PubMed
    Score: 0.400
  14. Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop. Circ Heart Fail. 2021 06; 14(6).
    View in: PubMed
    Score: 0.242
  15. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020 09; 8(9):873-884.
    View in: PubMed
    Score: 0.228
  16. Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension. Br J Pharmacol. 2020 04; 177(7):1457-1471.
    View in: PubMed
    Score: 0.221
  17. The application of big data to cardiovascular disease: paths to precision medicine. J Clin Invest. 2020 01 02; 130(1):29-38.
    View in: PubMed
    Score: 0.219
  18. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis. J Heart Lung Transplant. 2020 04; 39(4):289-299.
    View in: PubMed
    Score: 0.219
  19. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med. 2018 06 13; 10(445).
    View in: PubMed
    Score: 0.197
  20. Network Analysis to Risk Stratify Patients With Exercise Intolerance. Circ Res. 2018 03 16; 122(6):864-876.
    View in: PubMed
    Score: 0.192
  21. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension. FASEB J. 2016 07; 30(7):2511-27.
    View in: PubMed
    Score: 0.169
  22. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016 Mar 29; 133(13):1240-8.
    View in: PubMed
    Score: 0.167
  23. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015 Dec; 5(4):610-8.
    View in: PubMed
    Score: 0.165
  24. Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study. J Heart Lung Transplant. 2016 Mar; 35(3):342-351.
    View in: PubMed
    Score: 0.164
  25. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation. 2013 Jul 30; 128(5):512-23.
    View in: PubMed
    Score: 0.140
  26. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med. 2007 Feb; 13(2):189-97.
    View in: PubMed
    Score: 0.090
  27. Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging. Chest. 2021 Jul 13.
    View in: PubMed
    Score: 0.061
  28. Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience. Eur Heart J Cardiovasc Imaging. 2021 Jun 07.
    View in: PubMed
    Score: 0.061
  29. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension. Am J Respir Crit Care Med. 2020 01 15; 201(2):224-239.
    View in: PubMed
    Score: 0.055
  30. PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. Circ Res. 2017 10 27; 121(10):1136-1139.
    View in: PubMed
    Score: 0.047
  31. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model. J Am Coll Cardiol. 2016 05 03; 67(17):2032-46.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.